Overview
Title
To amend the Internal Revenue Code of 1986 to allow an investment credit for certain domestic infant formula manufacturing projects and to allow a domestic production credit for certain infant formula.
ELI5 AI
The Infant Formula Made in America Act of 2024 is like giving a money boost to companies that make baby formula in the U.S., so they don't have to bring it from other countries. They get rewards or "credits" when they spend money on making factories or making a lot of formula right here in America!
Summary AI
The Infant Formula Made in America Act of 2024 aims to amend the Internal Revenue Code to provide tax credits for specific domestic infant formula manufacturing projects. It introduces a new investment credit, offering a 30% tax break on investments for U.S. manufacturing projects of infant formula, but limits the total credits to $750 million. The bill also proposes a production credit, rewarding manufacturers $2 per pound of eligible U.S.-made infant formula, capped at 18 million pounds annually, and for up to five years per manufacturer. These measures are designed to support the domestic production of infant formula and reduce foreign dependency.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
General Summary of the Bill
The proposed legislation, titled the "Infant Formula Made in America Act of 2024," aims to amend the Internal Revenue Code of 1986 to support domestic infant formula manufacturing. The bill proposes two central tax credits. Firstly, a Domestic Infant Formula Manufacturing Investment Credit, which allows eligible businesses to claim a 30% tax credit on investments made in domestic infant formula manufacturing projects. Secondly, an Infant Formula Production Credit offers $2 for every pound of qualifying infant formula produced and sold in the United States, with certain restrictions on eligibility and credit amount.
Summary of Significant Issues
A key issue with the bill concerns the $750 million cap on total credits and the $150 million limit for individual projects under the investment credit section. These limits might either inadequately support large-scale manufacturing endeavors or favor a handful of large corporations, potentially impacting fair competition and equitable distribution of the tax benefits. Additionally, the aggregation rules could permit companies to circumvent revenue thresholds by structuring operations in certain ways, which might dilute the bill's intention to support smaller entities.
Another significant concern is the requirement for eligible projects to commence within three years and the possibility of recapture if conditions are unmet. This stipulation could deter companies from undertaking long-term, substantial investments due to its restrictive nature. The domestic-only sale requirement for infant formula might also conflict with international trade agreements, potentially limiting international firms from participating and triggering trade disputes.
Moreover, the dense language and complexity of the bill could present comprehension barriers for stakeholders unfamiliar with legal and tax vernacular, challenging effective engagement and compliance.
Broad Impact on the Public
The legislation could potentially bolster domestic production of infant formula, addressing supply chain vulnerabilities highlighted by recent shortages. This might lead to increased availability and reliability of this vital product for U.S. consumers, which is particularly significant for families reliant on infant formula. Furthermore, such tax incentives may stimulate economic activity in the manufacturing sector, potentially creating jobs and increasing investment in associated industries.
Impact on Specific Stakeholders
For small and medium-sized businesses in the infant formula industry, the bill provides opportunities to access financial credits, facilitating plant upgrades and production expansion. However, businesses slightly exceeding the $750 million revenue threshold, or those structured within larger entities, could find themselves at a disadvantage due to the current eligibility criteria.
For large-scale manufacturers, the caps on credit allocations might pose a hurdle in undertaking long-term, capital-intensive projects, as their financial plans might exceed the specified limits. On the international front, companies accustomed to exporting to the U.S. may face barriers, as the domestic-only requirement could limit their market participation and complicate adherence to global trade rules.
Overall, while the bill aims to boost domestic manufacturing capabilities and ensure a steady supply of infant formula, its effectiveness will largely depend on the careful management of credit allocations, clear communication of requirements, and ongoing evaluation of its impact across different scales of business operations.
Financial Assessment
The "Infant Formula Made in America Act of 2024" proposes significant financial incentives aimed at bolstering the domestic production of infant formula within the United States. The bill introduces two principal tax credits: an investment credit and a production credit. These credits are designed to encourage the development and expansion of infant formula manufacturing projects domestically.
Investment Credit
The investment credit detailed in the bill provides a 30% tax credit on the qualified investment for certain domestic infant formula manufacturing projects. However, this is subject to a cap of $150,000,000 per project and an overall credit cap of $750,000,000. This substantial allocation is intended to stimulate growth within the sector by supporting manufacturing endeavors.
However, these financial limits raise several issues:
Project and Aggregate Limits: The specified caps might not be adequate to support larger-scale projects and could inadvertently favor larger companies with substantial financial resources. Smaller entities, even if eligible, might be disadvantaged by the limitations, thereby affecting fair competition.
Aggregation Rules: By treating all associated persons as a single taxpayer, companies might explore restructuring to circumvent the $750,000,000 revenue threshold. This could undermine the bill's goal of primarily supporting smaller businesses.
Eligibility Criteria Focused on Revenue: The eligibility for this credit is determined solely by revenue, potentially excluding smaller businesses in high-revenue industries. A more holistic approach might consider other factors, such as regional economic conditions or industry-specific challenges.
Production Credit
The production credit offers $2 per pound of eligible infant formula manufactured and sold in the U.S., with a limit of 18 million pounds per year and available for up to five years per manufacturer. This measure aims to incentivize continuous domestic production and relieve the dependency on foreign imports.
The financial limitations applicable to this credit present another concern:
- Limit on Pounds of Formula: The cap on the amount of formula that qualifies could limit the potential for high-production companies to fully benefit from the credit. This could deter larger players from entering or expanding within the market.
Sunset and Recapture Provisions
The bill includes a sunset provision that disallows any credit allocations for projects commenced 10 years after the enactment. This poses a risk by potentially causing a rush to commence projects before the deadline, which could undermine the long-term strategic planning necessary for larger investments.
The recapture provisions define penalties if the terms of the project certification are not met. This could discourage long-term investments due to their restrictive nature, as businesses might fear the implications of failing to meet these conditions accidentally.
Conclusion
The financial references in the "Infant Formula Made in America Act of 2024" reflect a clear governmental intention to stimulate domestic production of infant formula through targeted tax incentives. However, the limitations and conditions pose challenges that may inadvertently skew the market towards larger entities while aiming to assist smaller businesses. Thorough exploration and potential revisions of these financial caps and criteria could enhance the bill's effectiveness in promoting a robust and competitive domestic infant formula industry.
Issues
The $750,000,000 credit cap and $150,000,000 per project limit specified in Section 48F might not support larger-scale projects adequately, or could disproportionately favor a few large companies, potentially affecting fair competition and distribution of benefits.
The aggregation rules under sections 48F and 45BB may allow some companies to structure their operations in a way that bypasses revenue limits, potentially undermining the intent of targeting smaller businesses.
The criteria for eligibility under Sections 2 and 48F are solely based on revenue without considering other factors like regional economic differences or industry-specific challenges, potentially excluding smaller businesses in high-revenue sectors.
The requirements for eligible projects to be placed in service within three years and the possibility for recapture if conditions are not met, as outlined in Section 48F, could discourage longer-term, large-scale investments due to their restrictive nature.
The domestic-only sale requirement for infant formula under Section 48F might conflict with international trade principles, limiting participation by qualified international producers and potentially inciting trade disputes.
The dense and complex language used throughout Section 48F may hinder understanding and compliance for stakeholders unfamiliar with tax or legal terminology, posing a risk to effective engagement and adherence.
The potential lack of clear timelines and procedures for review and redistribution of credits in Section 48F could lead to inefficiency and perceptions of favoritism or bias in credit allocation.
The definition of 'recapture event' in Section 48F is vague, leading to potential disputes or confusion over what circumstances could trigger recapture, which could adversely affect businesses' willingness to participate.
The sunset provision in Section 48F could lead to a rush or halt in project completion if companies are unable to meet the construction commencement deadline, impacting investment stability and predictability.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The section states that the official short title of the legislation is the "Infant Formula Made in America Act of 2024."
2. Domestic infant formula manufacturing investment credit Read Opens in new tab
Summary AI
The section provides a Domestic Infant Formula Manufacturing Investment Credit, which allows eligible taxpayers to receive a tax credit of 30% on investments in certain infant formula manufacturing projects in the United States. To qualify, the taxpayer's global revenue must be less than $750 million, and projects need certification confirming they re-equip, expand, or establish facilities to produce eligible infant formula.
Money References
- â(c) Definitions.âFor purposes of this sectionâ â(1) ELIGIBLE TAXPAYER.â â(A) IN GENERAL.âFor purposes of this section, the term âeligible taxpayerâ means a taxpayer if such taxpayerâs total global revenue for the calendar year that precedes the calendar year in which the taxpayer submits an application under subsection (d)(1)(A) does not exceed $750,000,000.
- â â(A) PROJECT AMOUNT.âThe amount of credit that may be allocated under paragraph (1) shall not exceed $150,000,000.
- â(B) AGGREGATE AMOUNT.âThe total amount of credits that may be allocated under paragraph (1) shall not exceed $750,000,000.
- â(C) SUNSET.âThe Secretary may not allocate any credit dollar amount with respect to any project that commences construction after the date that is 10 years after the date of the enactment of this section.
48F. Domestic infant formula manufacturing investment credit Read Opens in new tab
Summary AI
The Domestic Infant Formula Manufacturing Investment Credit provides a 30% tax credit to eligible U.S. taxpayers on investments made in projects that manufacture infant formula. To qualify, taxpayers must have global revenues under $750 million and meet specific criteria for eligible property and project approval, with the total credits capped at $750 million and no credits allocated to projects starting construction more than ten years after enactment.
Money References
- (A) IN GENERAL.âFor purposes of this section, the term âeligible taxpayerâ means a taxpayer if such taxpayerâs total global revenue for the calendar year that precedes the calendar year in which the taxpayer submits an application under subsection (d)(1)(A) does not exceed $750,000,000.
- â (A) PROJECT AMOUNT.âThe amount of credit that may be allocated under paragraph (1) shall not exceed $150,000,000.
- (B) AGGREGATE AMOUNT.âThe total amount of credits that may be allocated under paragraph (1) shall not exceed $750,000,000.
- (C) SUNSET.âThe Secretary may not allocate any credit dollar amount with respect to any project that commences construction after the date that is 10 years after the date of the enactment of this section.
3. Infant formula production credit Read Opens in new tab
Summary AI
The proposed section in the bill introduces an Infant Formula Production Credit for qualifying companies, which grants them $2 for each pound of eligible infant formula they produce and sell in the U.S., with a limit of 18 million pounds per year. The credit can only be claimed by companies with less than $750 million in global revenue or those who received it in the previous year, and it is available for up to five years.
Money References
- â(2) $2.
- â(b) Qualified taxpayer.âFor purposes of this section, the term âqualified taxpayerâ means, with respect to a taxable yearâ â(1) a taxpayer if such taxpayerâs total global revenue for the preceding taxable year does not exceed $750,000,000, or â(2) a taxpayer to whom a credit was allowed under this section in the preceding taxable year.
45BB. Infant formula production credit Read Opens in new tab
Summary AI
The section outlines a credit for companies that produce infant formula, where the credit is based on the pounds of formula sold in the U.S. multiplied by $2. A company can qualify if it has global revenue of $750 million or less or received the credit before, but there is a limit to how much formula can be counted and how long the credit can be claimed.
Money References
- (a) In general.âIn the case of a qualified taxpayer, for purposes of section 38, the infant formula production credit for any taxable year is an amount equal to the product ofâ (1) the amount in pounds (determined consistent with regulations issued under section 48F(g) with respect to liquid concentrate) of eligible infant formula manufactured by such taxpayer and sold for use in the United States during such taxable year, multiplied by (2) $2. (b) Qualified taxpayer.âFor purposes of this section, the term âqualified taxpayerâ means, with respect to a taxable yearâ (1) a taxpayer if such taxpayerâs total global revenue for the preceding taxable year does not exceed $750,000,000, or (2) a taxpayer to whom a credit was allowed under this section in the preceding taxable year. (c) Eligible infant formula defined.âFor purposes of this section, the term âeligible infant formulaâ has the meaning given such term in section 48F. (d) Limitations.â (1) MAXIMUM AMOUNT OF FORMULA.âFor purposes of determining the amount of the credit under subsection (a), the amount of eligible infant formula determined under subsection (a) with respect to any taxable year shall not exceed 18,000,000 pounds.